Adicet Bio Inc

+0.12 (+1.18%)
Earnings Announcements

Adicet Posts Q3 Loss Per Share Of $0.44

Published: 11/10/2021 21:45 GMT
Adicet Bio Inc (ACET) - Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates.
Q3 Loss per Share $0.44 Including Items.
On Track to Report Top-line Safety and Tolerability Data From Adi-001 Phase 1 Study in Non-hodgkin's Lymphoma (nhl) by Year End.
Qtrly Loss per Share $0.44.
Q3 Earnings per Share View $-0.44, Revenue View $2.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $4.19 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $0.88 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.